All the news Showing 10 of 15 articles from: Pegylated interferon and ribavirinGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Elbasvir/grazoprevir superior to sofosbuvir and pegylated interferon/ribavirin Michael Carter / 10 May 2016 New research has demonstrated the clear superiority of an oral combination of direct-acting antivirals (DAAs) over a regimen that combines a DAA with pegylated interferon and ribavirin for the treatment of chronic hepatitis ... Sustained Response to Interferon Is Durable in Children with Hepatitis C HIVandhepatitis.com / 28 May 2014 Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people Liz Highleyman / 10 October 2013 People co-infected with HIV and HCV, mostly with hepatitis C virus (HCV) genotype 3, responded about as well as HIV-negative people to interferon-based therapy after taking into account other factors associated ... Temperature increase after interferon-based HCV treatment linked to virological response Healio Hepatology / 25 July 2013 Hepatitis treatment debuts on WHO Model Essential Medicines List World Health Organization (press release) / 25 July 2013 Hepatitis C treatment gap in Europe: France doing well but Italy treated fewer than one in a hundred patients in 2010 Caspar Thomson / 23 May 2013 France led the world in the proportion of its hepatitis C patients who received treatment in 2010, but some countries in southern and eastern Europe had treatment rates that were almost tenfold ... HCV patients with late viral breakthrough have similar characteristics Healio Hepatology / 20 May 2013 Ribavirin Trough Affects Early HCV Response With Unfavorable IL28B Profile NATAP / 14 May 2013 Pakistan: Low cost Hepatitis C treatment: ‘Everything is heading in the right direction – on paper’ Express Tribune / 28 February 2013 Have a heart, save my liver! HepCoalition.org / 14 February 2013 ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive